Adalimumab 40 mg

BIOLOGICAL3 trials

Sponsors

Abbott, Janssen Research & Development, LLC, CARE ARTHRITIS LTD.

Conditions

Arthritis, RheumatoidOsteoarthritis, KneeRheumatoid Arthritis

Phase 2

Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

CompletedNCT00538902

AbbottRheumatoid Arthritis

Start: 2007-08-31End: 2009-12-31Updated: 2011-04-11

Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)

CompletedNCT02471118

CARE ARTHRITIS LTD.Osteoarthritis, Knee

Start: 2015-03-31End: 2021-03-31Updated: 2021-10-27

Phase 3

A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis

CompletedNCT02019472

Janssen Research & Development, LLCArthritis, Rheumatoid

Start: 2014-04-04End: 2016-08-17Updated: 2017-10-26

Related Papers

Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study.

2018-02-2622 citations

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases2016-06-24107 citations